215 related articles for article (PubMed ID: 26951092)
21. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases.
Adam J; Couturier J; Molinié V; Vieillefond A; Sibony M
Histopathology; 2011 Jun; 58(7):1064-71. PubMed ID: 21707708
[TBL] [Abstract][Full Text] [Related]
22. [E-cadherin expression and histopathological features in renal cell carcinomas].
Jin TX; Kakehi Y; Moroi S; Yoshida O
Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
[TBL] [Abstract][Full Text] [Related]
23. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
[TBL] [Abstract][Full Text] [Related]
24. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
[TBL] [Abstract][Full Text] [Related]
25. [Non-metastatic clear cell renal carcinoma: prognostic significance of morphometric and biomolecular factors].
Iurin AG
Vopr Onkol; 2009; 55(2):177-82. PubMed ID: 19514371
[TBL] [Abstract][Full Text] [Related]
26. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
[TBL] [Abstract][Full Text] [Related]
27. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
28. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
29. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.
Remzi M; Ozsoy M; Klingler HC; Susani M; Waldert M; Seitz C; Schmidbauer J; Marberger M
J Urol; 2006 Sep; 176(3):896-9. PubMed ID: 16890647
[TBL] [Abstract][Full Text] [Related]
30. CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma.
López JI; Erramuzpe A; Guarch R; Cortés JM; Pulido R; Llarena R; Angulo JC
APMIS; 2017 Feb; 125(2):128-133. PubMed ID: 28120493
[TBL] [Abstract][Full Text] [Related]
31. Comparison of tumor grade and stage with nuclear factor kappa b and p38 mitogene activated protein kinase expressions in renal cell cancer.
Ozbek E; Aliskan T; Otunctemur A; Calik G; Cakir S; Dursun M; Somay A
Arch Ital Urol Androl; 2012 Jun; 84(2):53-60. PubMed ID: 22908772
[TBL] [Abstract][Full Text] [Related]
32. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
33. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
[TBL] [Abstract][Full Text] [Related]
34. SLUG and SNAIL as Potential Immunohistochemical Biomarkers for Renal Cancer Staging and Survival.
Zivotic M; Kovacevic S; Nikolic G; Mioljevic A; Filipovic I; Djordjevic M; Jovicic V; Topalovic N; Ilic K; Radojevic Skodric S; Dundjerovic D; Nesovic Ostojic J
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569620
[TBL] [Abstract][Full Text] [Related]
35. Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.
Johnson TV; Ali S; Abbasi A; Kucuk O; Harris WB; Ogan K; Pattaras J; Nieh PT; Marshall FF; Osunkoya AO; Master VA
J Urol; 2011 Oct; 186(4):1213-7. PubMed ID: 21849188
[TBL] [Abstract][Full Text] [Related]
36. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
[TBL] [Abstract][Full Text] [Related]
37. [Study on clinicopathologic features and immunophenotype of 114 cases of renal cell carcinoma].
Zou H; Pang LJ; Hu WH; Li F; Li HA; Jiang JF; Liang WH; Sun ZZ; Wang C; Lang JY
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):726-31. PubMed ID: 19094705
[TBL] [Abstract][Full Text] [Related]
38. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
[TBL] [Abstract][Full Text] [Related]
39. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
40. Syncytial giant cell component. Review of 55 renal cell carcinomas.
Berzal Cantalejo F; Sabater Marco V; Alonso Hernández S; Jiménez Peña R; Martorell Cebollada MA
Histol Histopathol; 2004 Jan; 19(1):113-8. PubMed ID: 14702178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
